248 related articles for article (PubMed ID: 21641807)
1. Synthesis and biological evaluation of α-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture.
Steuer C; Gege C; Fischl W; Heinonen KH; Bartenschlager R; Klein CD
Bioorg Med Chem; 2011 Jul; 19(13):4067-74. PubMed ID: 21641807
[TBL] [Abstract][Full Text] [Related]
2. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.
Nitsche C; Steuer C; Klein CD
Bioorg Med Chem; 2011 Dec; 19(24):7318-37. PubMed ID: 22094280
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of nonsubstrate based inhibitors of the essential dengue and West Nile virus proteases.
Ganesh VK; Muller N; Judge K; Luan CH; Padmanabhan R; Murthy KH
Bioorg Med Chem; 2005 Jan; 13(1):257-64. PubMed ID: 15582469
[TBL] [Abstract][Full Text] [Related]
4. Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease.
Schüller A; Yin Z; Brian Chia CS; Doan DN; Kim HK; Shang L; Loh TP; Hill J; Vasudevan SG
Antiviral Res; 2011 Oct; 92(1):96-101. PubMed ID: 21763725
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold.
Aravapalli S; Lai H; Teramoto T; Alliston KR; Lushington GH; Ferguson EL; Padmanabhan R; Groutas WC
Bioorg Med Chem; 2012 Jul; 20(13):4140-8. PubMed ID: 22632792
[TBL] [Abstract][Full Text] [Related]
6. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
[TBL] [Abstract][Full Text] [Related]
7. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.
Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R
Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of small-molecular di-basic esters, amides and carbamates as flaviviral protease inhibitors.
Sundermann TR; Benzin CV; Dražić T; Klein CD
Eur J Med Chem; 2019 Aug; 176():187-194. PubMed ID: 31103899
[TBL] [Abstract][Full Text] [Related]
9. Thiazolidinone-peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture.
Nitsche C; Schreier VN; Behnam MA; Kumar A; Bartenschlager R; Klein CD
J Med Chem; 2013 Nov; 56(21):8389-403. PubMed ID: 24083834
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Dengue virus and West Nile virus proteases by click chemistry-derived benz[d]isothiazol-3(2H)-one derivatives.
Tiew KC; Dou D; Teramoto T; Lai H; Alliston KR; Lushington GH; Padmanabhan R; Groutas WC
Bioorg Med Chem; 2012 Feb; 20(3):1213-21. PubMed ID: 22249124
[TBL] [Abstract][Full Text] [Related]
11. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
[TBL] [Abstract][Full Text] [Related]
12. Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors.
Weigel LF; Nitsche C; Graf D; Bartenschlager R; Klein CD
J Med Chem; 2015 Oct; 58(19):7719-33. PubMed ID: 26367391
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
[TBL] [Abstract][Full Text] [Related]
14. A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease.
Bodenreider C; Beer D; Keller TH; Sonntag S; Wen D; Yap L; Yau YH; Shochat SG; Huang D; Zhou T; Caflisch A; Su XC; Ozawa K; Otting G; Vasudevan SG; Lescar J; Lim SP
Anal Biochem; 2009 Dec; 395(2):195-204. PubMed ID: 19682971
[TBL] [Abstract][Full Text] [Related]
15. Discovery, synthesis, and in vitro evaluation of West Nile virus protease inhibitors based on the 9,10-dihydro-3H,4aH-1,3,9,10a-tetraazaphenanthren-4-one scaffold.
Samanta S; Cui T; Lam Y
ChemMedChem; 2012 Jul; 7(7):1210-6. PubMed ID: 22550001
[TBL] [Abstract][Full Text] [Related]
16. High-throughput virtual screening lead to discovery of non-peptidic inhibitors of West Nile virus NS3 protease.
Huang D
Methods Mol Biol; 2012; 819():615-23. PubMed ID: 22183561
[TBL] [Abstract][Full Text] [Related]
17. A dual-purpose synthetic colloidal platform for protease mapping: substrate profiling for Dengue and West Nile virus proteases.
Marcon L; Kozak D; Battersby BJ; Chappell KJ; Fairlie DP; Young P; Trau M
Anal Biochem; 2008 May; 376(1):151-3. PubMed ID: 18312847
[TBL] [Abstract][Full Text] [Related]
18. Docking of noncompetitive inhibitors into dengue virus type 2 protease: understanding the interactions with allosteric binding sites.
Othman R; Kiat TS; Khalid N; Yusof R; Newhouse EI; Newhouse JS; Alam M; Rahman NA
J Chem Inf Model; 2008 Aug; 48(8):1582-91. PubMed ID: 18656912
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 1,3,4,5-tetrasubstituted 1H-pyrrol-2(5H)-one scaffold.
Gao Y; Samanta S; Cui T; Lam Y
ChemMedChem; 2013 Sep; 8(9):1554-60. PubMed ID: 23868614
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 2-{6-[2-(5-phenyl-4H-{1,2,4]triazol-3-ylsulfanyl)acetylamino]benzothiazol-2-ylsulfanyl}acetamide scaffold.
Samanta S; Lim TL; Lam Y
ChemMedChem; 2013 Jun; 8(6):994-1001. PubMed ID: 23619931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
